Source: Business Wire

Followers on Owler

Est. Annual Revenue

$100K-5.0M

Est. Employees

1-25

Co-Founder & CEO

Rachel Humphrey

CEO Approval Rating

90/100

Normunity is a Connecticut-based biotechnology company that researches and develops immunotherapies for the treatment of cancer.

Normunity received $75M in Series B Funding